<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Aachen_Lab_Glycogen_Characterization skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Aachen/Lab/Glycogen/Characterization</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="wrapper"><DIV id="main" class="clearfix"><NAV class="navbar navbar-default"><DIV class="dropdownbar"><DIV class="fluid-container"><DIV class="collapse navbar-collapse"><UL id="menu-header" class="nav navbar-nav navbar-left"><LI class="dropdown"><A href="#" data-toggle="dropdown" class="dropdown-toggle">Project</A></LI><LI><A class="menu-link" href="/Team:Aachen/InteractiveTour10">Interactive Journey</A></LI><LI><A class="menu-link" href="/Team:Aachen/Project/Overview">Overview</A></LI><LI><A class="menu-link" href="/Team:Aachen/Project/Background">Background</A></LI><LI><A class="menu-link" href="/Team:Aachen/Project/Outlook">Outlook</A></LI></UL><LI class="dropdown"><A href="#" data-toggle="dropdown" class="dropdown-toggle">Lab</A></LI><LI id=""><A class="menu-link" href="/Team:Aachen/Lab">Overview</A></LI><LI id=""><A class="menu-link" href="/Team:Aachen/Modeling">Modeling</A></LI><LI id="" class="dropdown"><A class="menu-link" href="/Team:Aachen/Lab/Methanol">Methanol</A></LI><LI><A href="/Team:Aachen/Lab/Methanol/Biobricks">Biobricks</A></LI><LI><A href="/Team:Aachen/Lab/Methanol/Polycistronic_Expression_Plasmid">Polycistronic Expression Plasmid</A></LI><LI><A href="/Team:Aachen/Lab/Methanol/Monocistronic_Diversity_Library">Monocistronic Diversity Library</A></LI><LI><A href="/Team:Aachen/Lab/Methanol/Characterization">Characterization</A></LI><LI id="" class="dropdown"><A class="menu-link" href="/Team:Aachen/Lab/Glycogen">Glycogen</A></LI><LI><A href="/Team:Aachen/Lab/Glycogen/Synthesis">Synthesis</A></LI><LI><A href="/Team:Aachen/Lab/Glycogen/Knockouts">Knockouts</A></LI><LI><A href="/Team:Aachen/Lab/Glycogen/Characterization">Characterization</A></LI><LI id=""><A class="menu-link" href="/Team:Aachen/Lab/Libraries">Libraries</A></LI><LI id="" class="dropdown"><A class="menu-link" href="/Team:Aachen/Lab/Bioreactor">Bioreactor</A></LI><LI><A href="/Team:Aachen/Lab/Bioreactor/Hardware">Hardware</A></LI><LI><A href="/Team:Aachen/Software">Software</A></LI><LI><A href="/Team:Aachen/Lab/Bioreactor/Characterization_of_Bioreactor">Characterization</A></LI><LI class="dropdown"><A href="#" data-toggle="dropdown" class="dropdown-toggle">Notebook</A></LI><LI id=""><A class="menu-link" href="/Team:Aachen/Notebook/Protocols">Protocols</A></LI><LI class="dropdown" id=""><A class="menu-link" href="/Team:Aachen/Notebook/Documentation">Documentation</A></LI><LI id=""><A class="menu-link" href="/Team:Aachen/Notebook/Construction_Manuals">Construction Manuals</A></LI><LI class="dropdown"><A href="#" data-toggle="dropdown" class="dropdown-toggle">Human Practice</A></LI><LI id=""><A class="menu-link" href="/Team:Aachen/Practices/Overview">Overview</A></LI><LI id=""><A class="menu-link" href="/Team:Aachen/Practices/Maker_Faire">Maker Faire</A></LI><LI id=""><A class="menu-link" href="/Team:Aachen/Practices/Community_Labs">Community Labs</A></LI><LI id=""><A class="menu-link" href="/Team:Aachen/Practices/tubefront">tubefront</A></LI><LI id=""><A class="menu-link" href="/Team:Aachen/Practices/Safety">Safety</A></LI><LI id=""><A class="menu-link" href="/Team:Aachen/Collaborations">Collaborations</A></LI><LI class="dropdown"><A href="#" data-toggle="dropdown" class="dropdown-toggle">Achievements</A></LI><LI><A class="menu-link" href="/Team:Aachen/Achievements#Judging">Judging</A></LI><LI><A class="menu-link" href="/Team:Aachen/Parts">Parts</A></LI><LI class="dropdown"><A href="#" data-toggle="dropdown" class="dropdown-toggle">Team</A></LI><LI id=""><A class="menu-link" href="/Team:Aachen/Attributions#Members">Members</A></LI><LI id=""><A class="menu-link" href="/Team:Aachen/Attributions#Partners">Partners</A></LI><LI id=""><A class="menu-link" href="/Team:Aachen/Attributions#Attributions">Attributions</A></LI></DIV></DIV></DIV></NAV><DIV class="container tour"><DIV class="tourBoundingBox" style="display:none;"><DIV class="tourBoundingBoxInner"><DIV class="parentTourItem "><A class="tourItemLabel" href="/Team:Aachen/InteractiveTour10">
					The Challenge
				</A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" href="/Team:Aachen/InteractiveTour20">
					The Team
				</A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" href="/Team:Aachen/InteractiveTour31">
					The Strategy
				</A></DIV><DIV class="expandedTour" style="display:none"><DIV class="expandedTourInner"><DIV class="childTourItem"><A class="tourItemLabel" href="/Team:Aachen/InteractiveTour31">
							Biological Approach
						</A></DIV><DIV class="childTourItem"><A class="tourItemLabel" href="/Team:Aachen/InteractiveTour32">
							The Bioreactor
						</A></DIV></DIV></DIV><DIV class="parentTourItem"><A class="tourItemLabel" href="/Team:Aachen/InteractiveTour41">
					The People
				</A></DIV><DIV class="expandedTour" style="display:none"><DIV class="expandedTourInner"><DIV class="childTourItem"><A class="tourItemLabel" href="/Team:Aachen/InteractiveTour41">
							Maker Faire
						</A></DIV><DIV class="childTourItem"><A class="tourItemLabel" href="/Team:Aachen/InteractiveTour42">
							Community Labs
						</A></DIV><DIV class="childTourItem"><A class="tourItemLabel" href="/Team:Aachen/InteractiveTour43">
							tubefront
						</A></DIV></DIV></DIV><DIV class="parentTourItem"><A class="tourItemLabel" href="/Team:Aachen/InteractiveTour51">
					The Solution
				</A></DIV><DIV class="expandedTour" style="display:none"><DIV class="expandedTourInner"><DIV class="childTourItem"><A class="tourItemLabel" href="/Team:Aachen/InteractiveTour51">
							Engineering
						</A></DIV><DIV class="childTourItem"><A class="tourItemLabel" href="/Team:Aachen/InteractiveTour52">
							Biology
						</A></DIV></DIV></DIV><DIV class="parentTourItem"><A class="tourItemLabel" href="/Team:Aachen/InteractiveTour60">
					The Future
				</A></DIV></DIV></DIV></DIV><DIV class="container container-primary"><DIV class="row"><H1><SPAN class="mw-headline" id="How_We_Approached_Glycogen_Characterization">How We Approached Glycogen Characterization</SPAN></H1><P>After building our mono- and polycistronic constructs, their characterization was the next and possibly most important step. In this process, we investigated both cell growth and glycogen formation to prove the accumulation of glycogen due to the overexpression of glycogen building genes and the knockout of glycogen degradation genes.
In our approaches, we wanted to examine the function of <I>glgCAB</I>, draw conclusions on fermentation conditions and estimate the increase in glycogen. Therefore, we did growth experiments with <I>Escherichia coli</I> BL21 Gold (DE3) and analysed respective samples via <A href="/Team:Aachen/Notebook/Protocols#Iodine_Staining" title="Team:Aachen/Notebook/Protocols">iodine staining</A> and <A href="/Team:Aachen/Notebook/Protocols#Dinitrosalicylic_Acid_Staining" title="Team:Aachen/Notebook/Protocols"> dinitrosalicylic acid staining</A>. Furthermore, we did glycogen purifications to apply a <A href="/Team:Aachen/Notebook/Protocols#Glycogen_Kit" title="Team:Aachen/Notebook/Protocols">glycogen kit</A>.
</P><H2><SPAN class="mw-headline" id="Achievements">Achievements</SPAN></H2><TABLE class="wikitable"><TBODY><TR><TH> Part </TH><TH> Gene </TH><TH><B>Result </B></TH></TR><TR><TD><A rel="nofollow" class="external text" href="http://parts.igem.org/Part:BBa_K1585321">K1585321</A></TD><TD><I>glgCAB</I></TD><TD> characterized by iodine staining and therefore improved <A rel="nofollow" class="external text" href="http://parts.igem.org/Part:BBa_K118016">BBa_K118016</A></TD></TR><TR><TD><A rel="nofollow" class="external text" href="http://parts.igem.org/Part:BBa_K1585320">K1585320</A></TD><TD><I>glgAB</I></TD><TD> characterized polycistronic BioBrick by iodine staining
</TD></TR><TR><TD><A rel="nofollow" class="external text" href="http://parts.igem.org/Part:BBa_K1585310">K1585310</A></TD><TD><I>glgA</I></TD><TD>  characterized monocistronic BioBrick by iodine staining
</TD></TR><TR><TD><A rel="nofollow" class="external text" href="http://parts.igem.org/Part:BBa_K1585311">K1585311</A></TD><TD><I>glgB</I></TD><TD> characterized monocistronic BioBrick by dinitrosalicylic acid staining
</TD></TR><TR><TD><A rel="nofollow" class="external text" href="http://parts.igem.org/Part:BBa_K1585351">K1585351</A></TD><TD> Δ<I>glgP</I></TD><TD> characterized gene knockout by iodine staining
</TD></TR></TBODY></TABLE><P><SPAN style="color:transparent">a</SPAN></P><H1><SPAN class="mw-headline" id="Iodine_staining">Iodine staining</SPAN></H1><P>Due to the great number of constructs that we aimed to screen, there was a need for a simple and rapid characterization method. Since <A href="/Team:Aachen/Notebook/Protocols#Iodine_Staining" title="Team:Aachen/Notebook/Protocols">iodine staining</A> meets these criteria, we chose the procedure for first characterzations.
Glycogen accumulation is highest in the stationary phase of bacterial growth <SUP id="cite_ref-1" class="reference"><A href="#cite_note-1">[1]</A></SUP>. We could also prove this by staining samples from different growth phases. Therefore, the following overnight cultures were grown to this level. To ensure the best comparison between different strains, the samples were adjusted to the same OD before staining. 
</P><H2><SPAN class="mw-headline" id="Results_from_iodine_staining">Results from iodine staining</SPAN></H2><P>Our first BioBrick that was successfully characterized by iodine staining is the glycogen synthase, GlgA. The cell pellet of GlgA turned dark brown when resuspened in iodine solution while the wild type cells changed to a light yellow. The iodine molecules interact with the helical structure in the glycogen and thereby change their absorbance and appear dark blue or black/brown. Therefore the dark color shows that more glycogen is present in the BL21 Gold (DE3) + <I>glgA</I> cells compared to the wild type. 
</P><DIV class="figraw figure-medium col-md-6"><TABLE><TBODY><TR><TD><B>Iodine staining GlgA vs. wild type</B>Cultivated in LB + 20 mM glucose, BL21 Gold (DE3) wild type + <I>glgA</I> stained distinctly darker than the wild type.
</TD></TR></TBODY></TABLE></DIV><P>
The <I>glgC</I> BioBrick, based on BBa_K118016 by Team Edinburg 2008, was fused with the well-characterized RBS B0034. The dark color shows that the strong effect of GlgC on glycogen accumulation was preserved.
</P><DIV class="figraw figure-medium col-md-6"><TABLE><TBODY><TR><TD><B>Iodine staining BL21 Gold (DE3) + <I>glgC</I> vs. BL21 Gold (DE3) wild type</B>Cultivated in LB and on LB + 40 mM glucose, BL21 Gold (DE3) wild type + <I>glgC</I> stained considerably darker than the wild type.
</TD></TR></TBODY></TABLE></DIV><P>
Iodine staining was also tested on cells cultivated in minimal medium M9. The result of the single knockout Δ<I>glgP</I> was that it was clearly darker than the wild type which proves a higher accumulation of glycogen. This shows that the absence of a glycogen phosphorylase has a strong effect on the glycogen production.
</P><DIV class="figraw figure-medium col-md-6"><TABLE><TBODY><TR><TD><B>Iodine staining  Δ<I>glgP</I> vs. wild type</B>Cultivated in M9, BL21 Gold Δ<I>glgP</I>  stained distinctly darker than the BL21 Gold (DE3) wild type.
</TD></TR></TBODY></TABLE></DIV><P>
Finally, after our polycistronic construct <I>glgCAB</I> was assembled in an expression vector, it was also cultivated on LB with 20 mM glucose and stained. In several trials, <I>glgCAB</I> was darker than the wild type. Compared to the already existing BioBrick (BBa_K118016)<I> glgC</I>, our polycistronic construct was colored more brown than blue.  This results from a higher braching frequency in the glycogen structure.<SUP id="cite_ref-2" class="reference"><A href="#cite_note-2">[2]</A></SUP>This indicates that the branching enzyme in our <I>glgCAB</I> is, in spite of a point mutation, functionally expressed and influences the glycogen structure.  
</P><DIV class="figraw figure-medium col-md-6"><TABLE><TBODY><TR><TD><B>Iodine staining BL21 Gold (DE3) + <I>glgCAB</I> vs. wild type</B>Cultivated in LB + 20 mM glucose, BL21 Gold (DE3) + <I>glgCAB</I>  stained distinctly darker than the BL21 Gold (DE3) wild type.
</TD></TR></TBODY></TABLE></DIV><DIV class="figraw figure-large col-md-6"><TABLE><TBODY><TR><TD><B>Iodine staining  BL21 Gold (DE3) + <I>glgCAB</I> vs. wild type vs. <I>glgC</I></B>Cultivated in LB + 20 mM glucose, BL21 Gold (DE3) + <I>glgCAB</I> and BL21 Gold (DE3) + <I>glgC</I> stained distinctly darker than the BL21 Gold (DE3) wild type. It can be observed that  the strain expressing <I>glgC</I> is more blue which indicates more linear glycogen. The <I>glgCAB</I> #1 strain  is very dark and more brownish which suggests a higher frequency of branches. This could result from the influence of the branching enzyme.
</TD></TR></TBODY></TABLE></DIV><P>
One of our final experiments was the combination of two of our characterized glycogen constructs. We transformed <I>glgCAB</I> into our  <I>E. coli</I> BL21 Gold (DE3) Δ<I>glgP</I> to achieve the highest glycogen accumulation. After staining both samples with iodine, we observed, that the cells with a combination of knockout and polycistronic plasmid, were even darker than the <I>E. coli</I> BL21 Gold (DE3) Δ<I>glgP</I> cells. 
</P><DIV class="figraw figure-medium col-md-6"><TABLE><TBODY><TR><TD><B>Iodine staining  BL21 Gold (DE3) Δ<I>glgP</I> + <I>glgCAB</I> vs. BL21 Gold (DE3) Δ<I>glgP</I></B>Cultivated in LB + 20 mM glucose, BL21 Gold (DE3) Δ<I>glgP</I> + <I>glgCAB</I> stained distinctly darker than BL21 Gold (DE3) Δ<I>glgP</I>. It shows that even higher glycogen accumulation can be achieved by combining overexpression of all three synthesis enzymes and the <I>glgP</I> knockout.
</TD></TR></TBODY></TABLE></DIV><H1><SPAN class="mw-headline" id="Dinitrosalicylic_Acid_Staining">Dinitrosalicylic Acid Staining</SPAN></H1><P>The iodine staining of strains containing <I>glgB</I> (branching enzyme) was not quite distinct. We still wanted to investigate the functionality of the strains. Therefore, we used <A href="/Team:Aachen/Notebook/Protocols#Dinitrosalicylic_Acid_Staining" title="Team:Aachen/Notebook/Protocols"> dinitrosalicylic acid staining (DNS)</A> for detection of reducing ends <SUP id="cite_ref-3" class="reference"><A href="#cite_note-3">[3]</A></SUP> which should correspond to the branching frequency. All samples of  <I>glgB</I> strains were compared to wild type samples. For best comparison the samples were grown to stationary phase and adjusted to the same OD before staining. Since every sugar or alkyl would have reacted with 3,5-dinitrosalicylic acid, we purified our samples before the staining. In order to identify the branching frequency, we analyzed the absorbance values of the purified samples compared to the absorbance values of hydrolyzed samples. By calculating the absorbance ratio of the non-hydrolyzed divided by the hydrolyzed samples, we aimed for information about the branches per glycogen unit. 
The reaction principle can be described as follows.
</P><DIV class="figraw figure-large col-md-6"><TABLE><TBODY><TR><TD><B>reaction principle</B></TD></TR></TBODY></TABLE></DIV><P><SPAN style="color:transparent">a</SPAN></P><P>3,5-Dinitrosalicylic acid reacts with the reducing ends to 3-Amino-5-Nitrosalicylic acid, resulting in a changed π-system and therefore a change in absorbance. During the reaction, the reducing ends are oxidized whereas one nitro group of 3,5-Dinitrosalicylic acid is reduced to an amino group of 3-Amino-5-Nitrosalicylic acid. The more free reducing ends are present the more 3-Amino-5-Nitrosalicylic acid will be formed. Thus, the absorbance will increase.
</P><H2><SPAN class="mw-headline" id="Results_from_Dinitrosalicylic_Acid_Staining">Results from Dinitrosalicylic Acid Staining</SPAN></H2><P>The absorbance of non-hydrolyzed samples of the <I>glgB</I> strain is higher than the absorbance of the wild type (see figure <I>DNS staining of hydrolyzed samples of the </I>glgB<I> strain and wild type</I>). To identify the amount of glycogen in the samples, we hydrolyzed the samples and applied our staining. Our results show that the number of branches in glycogen is higher in the <I>glgB</I> strain compared to the wild type (<I>DNS staining of non-hydrolyzed samples of the </I>glgB<I> strain and wild type</I>).
</P><DIV class="figure-double col-md-12"><DIV class="figure figure-doubleM col-md-6"><TABLE><TBODY><TR><TD><B>DNS staining of non-hydrolyzed samples of the <I>glgB</I> strain and wild type</B>The non-hydrolyzed samples of the <I>glgB</I> strain and wild type show that the overexpression of <I>glgB</I> leads to glycogen molecules with a higher number of branches compared to the wild type. Error bars show propagation of uncertainty.
</TD></TR></TBODY></TABLE></DIV><DIV class="figure figure-doubleM col-md-6"><TABLE><TBODY><TR><TD><B>DNS staining of hydrolyzed samples of the <I>glgB</I> strain and wild type</B>The hydrolyzed samples indicate that the glycogen amount is higher in the wild type compared to the <I>glgB</I> overexpressing strain. Error bars show propagation of uncertainty. Since cell fragments are still left in the samples, the blank also shows an absorbance. Therefore, the line does not go though the origin.
</TD></TR></TBODY></TABLE></DIV></DIV><P><SPAN style="color:transparent">a</SPAN></P><P>The non-hydrolyzed values divided by the hydrolyzed values generate a ratio. Based on this ratio we can identify the number of branches per glycogen unit. It indicates that the number of branches per unit is higher in the <I>glgB</I> strain compared to the wild type.
</P><DIV class="figure-double col-md-12"><DIV class="figure figure-doubleM col-md-6"><TABLE><TBODY><TR><TD><B>ratio of non-hydrolyzed and hydrolyzed DNS staining values of the <I>glgB</I> strain and wild type</B>Although the amount of glycogen is higher in the wild type (see figure above), the number of branches per glycogen unit is higher in the <I>glgB</I> overexpressing strain. Therefore the overexpression of <I>glgB</I> successfully increased the number of branches.  Error bars show propagation of uncertainty.
</TD></TR></TBODY></TABLE></DIV><DIV class="figure figure-doubleM col-md-6"><TABLE><TBODY><TR><TD><B>glycogen calibration curve</B>With the calibration curve we are able to identify the glycogen concentration of our samples. Error bars show propagation of uncertainty.
</TD></TR></TBODY></TABLE></DIV></DIV><P><SPAN style="color:transparent">a</SPAN></P><P>
The results of our experiments show that the overexpression of <I>glgB</I> leads to glycogen molecules with a higher number of branches compared to the wild type. Therefore, we proved the functionality of our <I>glgB</I> BioBrick.
</P><P><SPAN style="color:transparent">a</SPAN></P><H1><SPAN class="mw-headline" id="Growth_experiments">Growth experiments</SPAN></H1><P>In order to characterize the growth performance of our knockout strains and transformants, we did several growth experiments in shake flasks. By combining these experiments with iodine staining and HPLC analysis of respective samples, we aimed to draw conclusions on possible correlations between the accumulation of glycogen and growth rate. In general, the growth was observed by taking regular OD samples manually or executing the experiment in the <A rel="nofollow" class="external text" href="http://www.aquila-biolabs.de/new/product/cell-growth-quantifier%7C">Cell Growth Quantifier</A> (CGQ, Aquila Biolabs) for online measurement.
</P><P>
The first growth experiment was performed with <A rel="nofollow" class="external text" href="http://openwetware.org/wiki/Electrocompetent_Cells#Materials">electrocompetent</A>  BL21 Gold (DE3) single knockouts ∆<I>glgP</I> and ∆<I>glgX</I> in which we transformed <I>glgC</I> in pSB1A30. We compared these strains to the BL21 Gold (DE3) wild type in M9 medium by taking samples manually. As you can see below, the strains without a debranching enzyme enter the stationary phase earlier. This might be because glycogen cannot be used for cell growth. Strains additionally expressing GlgC have an overall lower OD, which indicates a metabolic burden due to the overexpression of <I>glgC</I>. 
</P><DIV class="figure-double col-md-12"><DIV class="figure figure-doubleM col-md-6"><TABLE><TBODY><TR><TD><B>Growth of single knockout strains</B>The growth perfomance was observed in 250 mL shake flasks in M9 medium with 6.6 mM NH<SUB>4</SUB>Cl  and 40 mM glucose. One could observe that ∆glgX+ glgC had a shorter lag-phase but entered the stationary phase earlier. The growth curve of the wild type and ∆glgP + glgC was relatively similar.
</TD></TR></TBODY></TABLE></DIV><DIV class="figure figure-doubleM col-md-6"><TABLE><TBODY><TR><TD><B>Growth of single knockout strains containing <I>glgC</I></B>The conditions were the same as for the growth experiments on the left.
</TD></TR></TBODY></TABLE></DIV></DIV><P>When we examined all three cultures via iodine staining, <I>∆glgP + glgC</I> was darker than the wild type. In HPLC analysis, we found out that we did not have nitrogen limitation in the stationary phase, which is necessary for glycogen accumulation.<SUP id="cite_ref-4" class="reference"><A href="#cite_note-4">[4]</A></SUP> After another experiment with the single knockouts in BL21 Gold (DE3) where the nitrogen concentration was too low, we optimized our M9 medium. Using this M9 medium (6,6 mM NH<SUB>4</SUB>Cl, 40 mM glucose) and doing online measurements in the CGQ, we were able to reproduce the results for the single knockout strains and the single knockout strains with <I>glgC</I>. Via iodine staining of samples in different growth phases, we could verify that most glycogen accumulation occured in stationary phase. 
</P><P>
When we cultivated <I>glgC</I>, <I>glgCAB</I> and the BL21 Gold (DE3) wild type in LB with 20 mM glucose, we observed that BL21 Gold (DE3) + <I>glgCAB</I> was able to grow in spite of expressing three additional genes. This is a promising precondition for high future glycogen production.  
</P><DIV class="figure-double col-md-12"><DIV class="figure figure-doubleM col-md-6"><TABLE><TBODY><TR><TD><B>Growth of BL21 Gold (DE3) containing <I>glgCAB</I></B>Despite of additional metabolic burden, the strain containing <I>glgCAB</I> reached the highest end OD on LB with 20 mM glucose
</TD></TR></TBODY></TABLE></DIV><DIV class="figure figure-doubleM col-md-6"><TABLE><TBODY><TR><TD><B>Iodine staining after the growth experiment</B>The darker iodine stain of this strain suggests that the strain expressed glgCAB and accumulated more glycogen in the stationary phase than the wild type and the strain with <I>glgC</I></TD></TR></TBODY></TABLE></DIV></DIV><P><SPAN style="color:transparent">a</SPAN></P><H1><SPAN class="mw-headline" id="Outlook">Outlook</SPAN></H1><H2><SPAN class="mw-headline" id="Feeding_experiments">Feeding experiments</SPAN></H2><P>To prove the hypothesis that other bioprocesses can be built upon bacterially produced glycogen, the following experiment is a practical approach. The expectation is that feeding a wild type culture in stationary phase with cooked cells containing <I>glgCAB</I> in an expression vector should initiate subsequent growth due to the additional glucose in the feed.  
</P><P><B>Procedure</B></P><UL><LI>inoculate three 25 ml maincultures of BL21 Gold (DE3) wild type in C-lim M9 medium from LB precultures</LI><LI>inoculate two 10 ml LB + 20 mM glucose cultures (one of wild type culture and one  containing <I>glgCAB</I> in psB1A30), induce the strain containing  <I>glgCAB</I> with IPTG</LI><LI>adjust the two feed cultures to the same OD, centrifuge, resolve in water, cell lyse and hydrolization</LI><LI>feed WT1 with WT, WT2 with CAB, WT3 with water (500 µl) </LI><LI>track growth curves</LI></UL><H2><SPAN class="mw-headline" id="HPLC_analysis">HPLC analysis</SPAN></H2><P>Another approach to measure the glycogen accumulation quantitatively would be the analysis of samples by<A href="/Team:Aachen/Notebook/Protocols#HPLC" title="Team:Aachen/Notebook/Protocols"> HPLC</A>. With this method purified glycogen can be directly measured or the glucose levels can be observed after glycogen hydrolysis. We worked on this approach but the main problem was that we did not have a reliable glycogen purification protocol. Hence, our samples could not be analyzed properly. Nevertheless, by optimizing this aspect the glycogen content of cells should be clearly visible as we have already seen correct peaks for the synthesis operon in the <I>glgP</I> knockout strain. 
</P><P><SPAN style="color:transparent">a</SPAN></P><H2><SPAN class="mw-headline" id="Combining_glycogen_synthesis_and_MCC_pathway">Combining glycogen synthesis and MCC pathway</SPAN></H2><P><B>MCC operon in Bl21 Gold (DE3) ∆<I>glgP</I></B></P><P>
Over the course of our project, we initially pursued working in the subgroups “methanol” and “glycogen”.  As our work progressed and first milestones were reached, we took a step forward and thought of ways to combine both aspects –methanol assimilation and glycogen accumulation- in one organism. Since the <I>glgP</I> single knockout in Bl21 Gold (DE3) gave good results regarding its growth performance and glycogen accumulation, we decided to transform the polycistronic construct of methanol assimilating genes (<I>mdh</I>,<I>hps</I>, <I>phi</I>, <I>xpk</I>) into this strain. We saw that this strain was able to grow on M9 with 0.522 M methanol. The most effective way of further optimizing its growth and methanol assmilitation is to apply promoters with different strengths.
</P><H2><SPAN class="mw-headline" id="Laboratory_Notebook"><A href="/Team:Aachen/Notebook/Documentation/Glycogen_Characterization" title="Team:Aachen/Notebook/Documentation/Glycogen Characterization">Laboratory Notebook</A></SPAN></H2><H2><SPAN class="mw-headline" id="References">References</SPAN></H2><OL class="references"><LI id="cite_note-1"><SPAN class="mw-cite-backlink"><A href="#cite_ref-1">↑</A></SPAN><SPAN class="reference-text">Romeo T, Preiss J. Genetic regulation of glycogen biosynthesis in Escherichia coli: in vitro effects of cyclic AMP and guanosine 5'-diphosphate 3'-diphosphate and analysis of in vivo transcripts. J Bacteriol. 1989 May;171(5):2773–2782</SPAN></LI><LI id="cite_note-2"><SPAN class="mw-cite-backlink"><A href="#cite_ref-2">↑</A></SPAN><SPAN class="reference-text"> Lengeler J., Drews G., Schlegel H. Biology of the Prokaryotes, page 194, 9.5.2</SPAN></LI><LI id="cite_note-3"><SPAN class="mw-cite-backlink"><A href="#cite_ref-3">↑</A></SPAN><SPAN class="reference-text">S. K. Meur, V. Sitakara Rao, and K. B. De. Spectrophotometric Estimation of Reducing Sugars by Variation of pH. Z. Anal. Chem. <B>283</B>, 195-197 (1977)</SPAN></LI><LI id="cite_note-4"><SPAN class="mw-cite-backlink"><A href="#cite_ref-4">↑</A></SPAN><SPAN class="reference-text">Fung T. et. al. 2013. Residual Glycogen Metabolism in Escherichia coli is Specific to the Limiting Macronutrient and Varies During Stationary Phase. Journal of Experimental Microbiology and Immunology (JEMI)</SPAN></LI></OL></DIV><DIV class="hexagon-bg"><DIV class="hexagon"><DIV class="colorable fill"><CENTER><A href="#">▲</A></CENTER></DIV></DIV></DIV></DIV></DIV></DIV><DIV class="footer"><DIV class="bar"><DIV class="bar-wrap"><DIV class="disclaimer"><A href="mailto:igem@rwth-aachen.de">Contact</A></DIV><DIV class="copyright">CC-BY-SA iGEM Aachen 2015</DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>